LYNGE, DENMARK — WS Audiology (WSA), the parent company of hearing aid brands Signia and Widex, reported 2% organic revenue growth for its 2025/26 financial year, with improved profitability despite slower sales through its wholesale hearing aid business. The company generated €2.54 billion (~$2.79 billion) in revenue during the 12 months ending September 30, 2026....
Continue reading at Hearing Health Matters
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable clinical change — this is a corporate financial update with no direct implications for audiological practice.
WSA's modest growth amid weak wholesale demand signals ongoing market softness that could affect product availability, pricing, and competitive dynamics for clinic owners.
- 01WS Audiology posted 2% organic revenue growth for its 2025/26 financial year.
- 02Profitability improved despite slower wholesale hearing aid sales.
- 03New product launches from both Signia and Widex brands were highlighted.
- 04Wholesale channel weakness suggests potential downstream pressure on independent dispensers.
- 05Report reflects broader industry trends of moderate, not rapid, market expansion.
WS Audiology achieved 2% organic revenue growth for its 2025/26 financial year.
press releasesupportedWSA improved profitability despite slower wholesale hearing aid sales.
press releasesupported